What is the pearsin?

Perazine is antipsychotic drugs, which, according to the manufacturer, is known by different trade names in different countries. It can be used orally or injections to treat psychiatric disorders such as acute psychotic episodes and schizophrenia. Usually it is only available on the basis of the regulation and the prescribed dose and the regime should not be exceeded without discussion with the prescribed physician. Other medicines belonging to this class include chlorpromazine and fluphenazine. Medicines belonging to this class can share the mechanism of action and potential for adverse effects, albeit to varying degrees.

It is assumed that phenothiazins, including pearin, are assumed by blocking dopamine receptors in the brain. Dopamine is a chemical neurotransmitter that can be too active in people with psychiatric disorders such as schizophrenia. Brain receptors are blocked by phenothiazines of dopamine and control of symptoms of schizophrenia or psychosis. Can be used in an acute environment to manage a psychotic episode or long -term asmaintenance treatment in psychosis or schizophrenia. Perezine is used orally or as an injection that is usually given inwardly, ie injected into the muscle.

As with any medicine, all phenothiazins, including pearsin, can interact with other medicines. Other prescribed medicines must be discussed with the treated physician as if any over -the -counter, homeopathic or complementary drugs were. Complete publication of parallel therapies minimizes the chance of interacting between pearsin and other.

The side effects of pearsin may include effects on muscles or nerves that can cause symptoms such as tongue protrusion, rigidity or spasing of muscles, involuntary muscle movements, most often face and restlessness. Other adverse effects may include cardiovascular side effects and gastrointestinal effects. If there should be any adverse effect, it should be sought medicalHelp.

Due to the potential for pearlings to cause a number of side effects, it may be contraindicated in patients with some basic clinical disorders. For this reason, they should be published by a prescribing physician prior to the start of placing with placing. Pregnancy, required pregnancy and lactation should also be discussed because these may affect the choice of treatment.

IN OTHER LANGUAGES

Was this article helpful? Thanks for the feedback Thanks for the feedback

How can we help? How can we help?